![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Thomas M. Narang D. Lakshmy R. Gupta R. Naik N. Maulik S.
Publisher: Springer Publishing Company
ISSN: 0920-3206
Source: Cardiovascular Drugs and Therapy, Vol.20, Iss.1, 2006-02, pp. : 37-44
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Boudoulas H Georgiadou P Iliodromitis EK Varounis C Mavroidis M Kolokathis F Andreadou I Psarras S Capetanaki Y Kremastinos D Th
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Drug Investigation, Vol. 30, Iss. 7, 2010-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
High-dose atorvastatin decreases carotid inflammation in patients with carotid artery disease
Inpharma, Vol. 1, Iss. 1633, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Fogari Roberto Preti Paola Zoppi Annalisa Lazzari Pierangelo Corradi Luca Fogari Elena Ciccarelli Leonardina Derosa Giuseppe
European Journal of Clinical Pharmacology, Vol. 62, Iss. 10, 2006-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The association between inflammation markers, coronary artery disease and smoking
General Pharmacology, Vol. 39, Iss. 3, 2002-08 ,pp. :